Related Experiment Video
Updated: May 10, 2026
Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
Intraoperative device closure of subaortic ventricular septal defects
Lin Liu1, Tian Li Zhao, Yi Feng Yang
1The Stomatology Center, The Second Xiang Ya Hospital, Central South University, Changsha, Hunan, PR, China.
Objectives:
To evaluate the safety and the indication for percardiac device closure of subaortic ventricular septal defects (VSDs) under guidance of transesophageal echocardiography.
Methods:
A total of 62 patients with VSDs immediately below the aortic valve underwent percardiac device closure without cardiopulmonary bypass.
Results:
There were no deaths. Of 62 patients, 52 (83.9%) underwent successful closure and 10 (16.1%) were converted to open-heart surgery due to tricuspid regurgitation, aortic regurgitation, and a residual shunt. Multiple logistic regression analysis showed the type and diameter of VSD were associated with the failure of device closure. There were no severe adverse events. Follow-up ranged from 13 to 31 months (mean, 22.3 ± 5.2 months). Early and late complications occurred in 10 patients (19.2%) and two patients (3.8%), respectively.
Conclusions:
Excellent short-term results can be achieved in selected patients with percardiac device closure of subaortic ventricular septal defects.
